MxP^® Quant 500 XL kit

biocrates’ team of experts is highly professional, the analytical team is meticulous and knowledgeable about their workflow from sample prep to data analysis. The data analysis solutions brought me the efficiency and enabled me to focus on result interpretation for my research program. I am confident in continuing work with the biocrates team for my discoveries in future studies.

Ru Wei, PhD
Scientific Director, Proteomics, Chemical Biology & Proteomics, Biogen, USA

One challenge we face in clinical research is the limitation of the number of precious samples and the unique nature of each sample. It can be difficult to acquire matched controls for every study. We tested the QMDB and the various filter options matched well to study groups and the results aligned with our control groups. Reassurance by the QMDB helped us to verify that our results were within normal ranges and provide further power to our study.

Teodoro Bottiglieri, PhD
Director of Research, Center of Metabolomics; Baylor Scott & White Research Institute, USA

Our institute was looking for a standardized and validated approach to further expand our metabolomics portfolio. In general, LC-MS-based methods lack comparability and robustness. In addition, most self-developed or commercially available targeted approaches do not cover a broad spectrum of metabolites. Therefore, we use the MxP® Quant 500 XL kit on a routine base as a certified lab, because it is the most comprehensive solution for quantitative results on small molecules and lipids and complementary to our NMR-based metabolomics panel.

Dr. Sven Schuchardt
Head of Bio- and Environmental Analytics, Fraunhofer ITEM – Institute of Toxicology and Experimental Medicine, Germany